Summary of Flow Cytometric Analysis of Human Leukemias
| Type of Leukemia . | No. of Samples Analyzed . | No. of Samples Positive for (%)* . | ||||
|---|---|---|---|---|---|---|
| λ5 . | VpreB . | pre-BCR . | μH Chain . | L Chain (κ or λ) . | ||
| Non–B-, non–T-ALL | 56 | 46 (82) | 49 (88) | 13 (23) | 19 (34) | 0 (0) |
| Mature B-ALL | 3 | 0 (0) | 0 (0) | 0 (0) | 3 (100) | 3 (100) |
| T-ALL | 2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| AML | 2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Type of Leukemia . | No. of Samples Analyzed . | No. of Samples Positive for (%)* . | ||||
|---|---|---|---|---|---|---|
| λ5 . | VpreB . | pre-BCR . | μH Chain . | L Chain (κ or λ) . | ||
| Non–B-, non–T-ALL | 56 | 46 (82) | 49 (88) | 13 (23) | 19 (34) | 0 (0) |
| Mature B-ALL | 3 | 0 (0) | 0 (0) | 0 (0) | 3 (100) | 3 (100) |
| T-ALL | 2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| AML | 2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
All samples were cytoplasmically stained with the specific MoAbs and analyzed by flow cytometer as described in Materials and Methods.